Eriko Katsuta

25PUBLICATIONS
56CO-AUTHORS
Communications engineering not elsewhere classifiedMedical biochemistry - proteins and peptides (incl. medical proteomics)Molecular targetsPredictive and prognostic markersGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Aug 13, 2026
Correction: Tokumaru et al. High Expression of microRNA-143 Is Associated with Favorable Tumor Immune Microenvironment and Better Survival in Estrogen Receptor Positive Breast Cancer. Int. J. Mol. Sci. 2020, 21, 3213.

|Jan 14, 2026
6-Phosphogluconate dehydrogenase promotes mitochondrial fusion and immune suppression in tumor-associated monocytic suppressor cells.

Saeed Daneshmandi, Qi Yan, Eduardo Cortes Gomez

|Dec 30, 2025
Advances and Challenges in Drug Screening for Cancer Therapy: A Comprehensive Review.

Shohei Motohashi, Eriko Katsuta, Daisuke Ban

|Nov 13, 2025
Comparative analysis of streptozocin-based regimen and capecitabine-temozolomide therapy in advanced pancreatic neuroendocrine neoplasms: influence of tumor grade and Ki-67 index.

Yohei Tabe, Hiroaki Ono, Satoshi Matsui

|Aug 14, 2025
Scaffold-Free Functional Deconvolution Identifies Clinically Relevant Metastatic Melanoma EV Biomarkers.

Shin-La Shu, Shawna Benjamin-Davalos, Xue Wang

|Aug 04, 2025
Deciphering neutrophil dynamics in the focal lesion tumor microenvironment to overcome immunosuppression in multiple myeloma.

Joshua Rivera, Qi Yan, Saeed Daneshmandi

Pageof 5

Frequent Collaborators

16 joint publications

Kazuaki Takabe

5 joint publications

Yoshihisa Tokumaru

4 joint publications

Masanori Oshi

3 joint publications

Philip L McCarthy